Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-mFBG for Imaging Myocardial Sympathetic Innervation in Subjects Without and With Heart Disease
NCT04535193Phase 2Active, not recruiting
- Sponsor
- Innervate Radiopharmaceuticals
- Start
- Nov 2021
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of florbenguane F-18 in heart failure (HF), sponsored by Innervate Radiopharmaceuticals. Started Nov 2021; status: active, not recruiting.
02
Drugs
florbenguane F-18
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT04535193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04535193.